Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927693 · ClinicalTrials.gov registry record · NA
Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,137
- Enrollment target
NCT00927693: Completed NA study, sponsored by Cedars-Sinai Medical Center.
NCT00927693 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 2,137 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00927693, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,137 participants
- Enrollment target
Study Summary
Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CAC) scanning provides clinical benefit thus improving patient outcomes in asymptomatic subjects with intermediate coronary artery disease (CAD) risk. Additionally, the study is designed to assess the value of combining the CAC scan with the Framingham risk score (FRS) and measurements of serum or plasma biomarkers to predict outcomes.
Interventions
- OTHER Coronary Artery Calcium (CAC) Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,137 participants |
| Start Date | 2001-02 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT00927693 record still lists
NCT00927693 is an interventional study that assigns participants to a tested intervention. Its 2,137 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher).
The record links to 0 conditions, and to 1 intervention - of which Coronary Artery Calcium (CAC) Scan is the first listed.
NCT00927693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00927693 about?
NCT00927693 is a clinical study titled "Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)". Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CA...
What is the current status of trial NCT00927693?
This trial is currently completed. It is a NA study. The enrollment target is 2,137 participants. The study started on 2001-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00927693?
The interventions under investigation include: Coronary Artery Calcium (CAC) Scan (OTHER).
Who is sponsoring clinical trial NCT00927693?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00927693's enrollment target sits among peer trials
2,137 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia